Osteopontin, CD44, and NFκB Expression in Gastric Adenocarcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose ; Osteopontin (OPN) binds to CD44 and nuclear factor-κB (NFκB) and OPN mediates tumorigenesis, invasion and metastasis, but the interrelationships between OPN, CD44 and NFκB are not fully understood, and especially in gastric carcinogenesis. We examined the expressions of OPN, CD44, and NFκB in untreated gastric adenocarcinomas. Materials and Methods ; The materials from 211 cases of gastric adenocarcinoma were immunostained for OPN, CD44 and NFκB by using a tissue microarray. The OPN mRNA expression was measured in 10 cases by performing real-time RT-PCR. Results ; The expression of OPN, CD44 and NFκB was noted in 61.7%, 11.4% and 26.6% of the adenocarcinoma tissues, respectively. No significant correlation was detected among the expressions of these proteins. The OPN protein expression was negatively correlated with angioinvasion (p<0.05) and patient survival (p<0.05), whereas the CD44 and NFκB protein expressions were not correlated with any of the clinicopathological factors we examined. The depth of invasion, lymph node status and perineural invasions were rognostic factors based on the Cox analysis. The OPN mRNA expression showed no significant difference between the adenocarcinoma and the paired normal mucosa on real-time RT-PCR. Conclusion ; OPN may have a currently undetermined role in gastric carcinogenesis, and CD44 and NF κB may have minor roles in gastric adenocarcinoma.
Abstract
Purpose ; Osteopontin (OPN) binds to CD44 and nuclear factor-κB (NFκB) and OPN mediates tumorigenesis, invasion and metastasis, but the interrelationships between OPN, CD44 and NFκB are not fully understood, and especially in gastric carcinogenesis. We examined the expressions of OPN, CD44, and NFκB in untreated gastric adenocarcinomas. Materials and Methods ; The materials from 211 cases of gastric adenocarcinoma were immunostained for OPN, CD44 and NFκB by using a tissue microarray. The OPN mRNA expression was measured in 10 cases by performing real-time RT-PCR. Results ; The expression of OPN, CD44 and NFκB was noted in 61.7%, 11.4% and 26.6% of the adenocarcinoma tissues, respectively. No significant correlation was detected among the expressions of these proteins. The OPN protein expression was negatively correlated with angioinvasion (p<0.05) and patient survival (p<0.05), whereas the CD44 and NFκB protein expressions were not correlated with any of the clinicopathological factors we examined. The depth of invasion, lymph node status and perineural invasions were rognostic factors based on the Cox analysis. The OPN mRNA expression showed no significant difference between the adenocarcinoma and the paired normal mucosa on real-time RT-PCR. Conclusion ; OPN may have a currently undetermined role in gastric carcinogenesis, and CD44 and NF κB may have minor roles in gastric adenocarcinoma.
참고문헌 (24)
- Fock KM, "Asia-Pacific consensus guidelines on gastric cancer prevention", J Gastroenterol Hepatol, 23, pp.351~365 (2008)
- Yasui W, "Molecular pathobiology of gastric cancer", Scand J Surg, 95, pp.225~231 (2006)
- Guarino V, "Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness", J Clin Endocrinol Metab, 90, pp.5270~5278 (2005)
- Cook AC, "Osteopontin induces multiple changes in gene expression that reflect the six ‘hallmarks of cancer’ in a model of breast cancer progression", Mol Carcinog, 43, pp.225~236 (2005)
- Irby RB, "Osteopontin regulates multiple functions contributing to human colon cancer development and progression", Clin Exp Metastasis, 21, pp.515~523 (2004)
- Tuck AB, "Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways", Oncogene, 22, pp.1198~1205 (2003)
- Tuck AB, "The role of osteopontin in breast cancer: clinical and experimental studies", J Mammary Gland Biol Neoplasia, 6, pp.419~429 (2001)
- Murai T, "Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration", J Biol Chem, 279, pp.4541~4550 (2004)
- Philip S, "Osteopontin induces nuclear factor ?B-mediated promatrix metalloproteinase-2 activation through IκBα", IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways, 2003, pp.278, 14487~14497
- Philip S, "Osteopontin stimulates tumor growth and activation of promatrix metalloproteinases-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells", J Biol Chem, 276, pp.44926~44935 (2001)
- Renault MA, "UTP induces osteopontin expression through a coordinate action of NFkB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells", J Biol Chem, 280, pp.2708~2713 (2005)
- Samant RS, "Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NFkB activation", Mol Cancer, 6, pp.6~15 (2007)
- Kim JY, "Cyclooxygenase-2 and c-erbB-2 expression in gastric carcinoma assessed using tissue microarrays", Appl Immunohistochem Mol Morphol, 12, pp.67~70 (2004)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method", Methods, 25, pp.402~408 (2001)
- Weber GF, "The metastasis gene osteopontin: a candidate target for cancer therapy", Biochem Biophys Acta, 1552, pp.61~85 (2001)
- Eschrich S, "Molecular staging for survival prediction of gastric cancer patients", J Clin Oncol, 23, pp.3526~3535 (2005)
- Wu CY, "Elevated plasma osteopontin associated with gastric cancer development, invasion and survival", Gut, 56, pp.782~789 (2007)
- Coppola D, "Correlation of osteopontin protein expression and pathological stage across a side variety of tumor histologies", Clin Cancer Res, 10, pp.184~190 (2004)
- Selkirk SM, "Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal", J Neurooncol, 86, pp.285~296 (2008)
- Matsuzaki H, "Osteopontin as biomarker in early invasion by squamous cell carcinoma in tongue", J Oral Pathol Med, 36, pp.30~34 (2007)
- Lee JL, "Osteopontin promotes integrin activation through outside-in and inside-out mechanism:OPN-CD44v interaction enhances survival in gastrointestinal cancer cells", Cancer Res, 67, pp.2089~2097 (2007)
- Wai PY, "Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis", Carcinogenesis, 26, pp.741~751 (2005)
- Bourguignon LY, "Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells", J Biol Chem, 284, pp.2657~2671 (2009)
- Orian-Rousseau V, "CD44 is required for two consecutive steps in HGF", c-Met signaling, 2002, pp.16, 3074~3086